دورية أكاديمية

The effects of glucocorticoids and immunosuppressants on cancer outcomes in checkpoint inhibitor therapy

التفاصيل البيبلوغرافية
العنوان: The effects of glucocorticoids and immunosuppressants on cancer outcomes in checkpoint inhibitor therapy
المؤلفون: Sebastian Bruera, Maria E. Suarez-Almazor
المصدر: Frontiers in Oncology, Vol 12 (2022)
بيانات النشر: Frontiers Media S.A.
سنة النشر: 2022
المجموعة: Directory of Open Access Journals: DOAJ Articles
مصطلحات موضوعية: checkpoint inhibitor therapy, glucocorticoids, immunosuppressants, cancer, immunotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: The emergence of checkpoint inhibitors has created a paradigm shift for the treatment of various malignancies. However, although these therapies are associated with improved survival rates, they also carry the risk of immune-related adverse events (irAEs). Moderate to severe irAEs are typically treated with glucocorticoids, sometimes with the addition of immunosuppressants as steroid-sparing therapy. However, it is unclear how glucocorticoids and immunosuppressants may impact cancer survival and the efficacy of immune checkpoint therapy on cancer. In this narrative review, we discuss the effects of glucocorticoids and immunosuppressants including methotrexate, hydroxychloroquine, azathioprine, mycophenolate mofetil, tumor-necrosis factor (TNF)-inhibitors, interleukin-6 inhibitors, interleukin-1 inhibitors, abatacept, rituximab, and Janus kinase inhibitors (JAKi) on cancer-specific outcomes in the setting of immune checkpoint inhibitor use.
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 2234-943X
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2022.928390/fullTest; https://doaj.org/toc/2234-943XTest; https://doaj.org/article/f8cf10ea3eb8431fa82943dcf5fe9af9Test
DOI: 10.3389/fonc.2022.928390
الإتاحة: https://doi.org/10.3389/fonc.2022.928390Test
https://doaj.org/article/f8cf10ea3eb8431fa82943dcf5fe9af9Test
رقم الانضمام: edsbas.592D49FD
قاعدة البيانات: BASE
الوصف
تدمد:2234943X
DOI:10.3389/fonc.2022.928390